Welcome to our Evotec Blog.

Hope you will find our articles and resources relevant for your projects and interests.

Our experts are available for any additional information and to assist with your project challenges!

Just contact us.

 

 

Blogs

Year

    Evotec and GARDP announce new partnership to discover novel antibiotics

    Evotec and Galapagos enter into collaboration in the field of Fibrosis

    Evotec receives milestone payment for start of Phase II clinical trial

    Evotec and LEO Pharma form drug discovery alliance targeting dermatological conditions

    Evotec and Immuneering to collaborate on Artificial Intelligence (“AI”) driven ligand identification for rare hereditary metabolic diseases

    Ferring and Evotec form strategic research alliance in reproductive medicine and women’s health

    Evotec and Celgene expand IPSC collaboration to include additional cell lines

    Evotec signs agreement with Sanofi to advance early stage academic research into novel therapeutic candidates

    Evotec publishes DDup 7 – Kidney diseases 2.0

    Evotec and Almirall enter into research collaboration in the field of dermatological diseases

    Evotec AG listed in MDAX

    Evotec and Celgene enter partnership in the field of targeted protein degradation

    Yumanity Therapeutics announces first clinical candidate for the potential treatment of Parkinson’s disease

    Evotec and CHDI Foundation extend ongoing collaboration to fight Huntington's disease

    Evotec and CENTOGENE sign global strategic partnership on drug discovery projects in rare genetic diseases

    Evotec and Novo Nordisk form strategic research alliance in diabetes and obesity

    Evotec partner Haplogen enters into collaboration with Bayer

    Evotec repays 50% of € 140 m acquisition loan

    Evotec receives milestone payment for start of Phase II trial in its multi-target alliance with Bayer

    Evotec confirm closing of transaction with Sanofi to accelerate infectious disease research and development

    Evotec achieves second milestone in diabetes alliance with Sanofi

    Evotec and Sanofi sign definitive agreement to combat infectious diseases

    Evotec forms academic BRIDGE 'LAB591’ with Arix Bioscience and Fred Hutchinson Cancer Research Center

    Evotec and Celgene expand IPSC collaboration to include additional cell lines

    Evotec and Celgene enter into strategic oncology partnership

    Evotec reports First Quarter 2018 results and provides Corporate update

    Evotec and Carna Biosciences collaborate on INDiGO platform

    Evotec expands CRISPR-based technology offering with licence from ERS genomics

    Evotec and Bayer Advance Third Endometriosis Programme into Phase I Clinical Development

    Evotec forms collaboration with Petra Pharma on INDiGO platform

    Evotec launches INDiGO®, a unique integrated drug development solution for accelerating early drug candidates into the clinic

    Evotec and Apeiron Achieve First Milestone in Immuno-Oncology Alliance with Sanofi

    Evotec Enters into Research Collaboration with CRTD to Discover Novel Therapies for Retinal Diseases

    Evotec’s Academic Bridge LAB282 with Oxford University Celebrating One Year of Impact

    Evotec Receives Clinical Milestone as Part of its Discovery Alliance with Boehringer Ingelheim

    Evotec AG announces first nine-month 2017 results and corporate update

    Evotec joins forces with Academic Leaders to accelerate Drug Discovery in kidney diseases and build “Neplex”

    Evotec AG to report first nine-month 2017 results on 08 November 2017

    New Research by Cyprotex on Transporter DDI Published in Pharmacology Research & Perspectives

    Evotec and Tesaro Enter Strategic Partnership To Discover Novel Immuno-Oncology Agents

    Evotec Achieves First Milestone In Neurodegeneration Alliance With Celgene

    Evotec and MaRS Innovation Establish Academic Bridge “LAB150” in Toronto

    Evotec to Acquire Aptuit, Expanding Leadership in External Innovation

    Read our article on Form Selection Problems in the Pharmaceutical Field

    Aptuit Announces Strategic Provider Agreement with Regulus Therapeutics

    Aptuit's Collaboration with MGH Covered on OneNucleus Spring 2017 Newsletter

    Why We Need a Culture of International Collaboration to Fight Antibiotic Resistance

    Aptuit Announces Alignment of Organizational Structure to Integrated Solution Delivery: Henning Steinhagen Appointed as President, Research and Development Operations

    Pharma's Almanac on Aptuit's Collaboration with Bioversys

    Aptuit Selected as a Winner of Life Science Leader Global Award for Contract Drug Manufacturer in Multiple Categories

    Bioversys AG and Aptuit Announce Collaboration to Identify Novel Approaches to Treat Serious Infections from Gram-negative Pathogens

    Dementia Discovery Fund Acquires Small Molecule Library and Enters Strategic Partnership with Aptuit to Kickstart Dementia Drug Discovery Programmes

    SAMDI Tech, Inc. and Aptuit Announce Drug Discovery Screening Partnership

    Aptuit announces drug discovery collaboration with Massachusetts General Hospital (MGH) to identify novel treatments for Gram-negative infections

    Chronos Therapeutics partners with Aptuit for addictive behaviour programmes

    Aptuit and Chiesi Initiate Integrated Discovery Project to Identify Novel Compounds for the Treatment of Idiopathic Pulmonary Fibrosis

    Aptuit Announces Expansion of Compound Library

    Aptuit names Peter Gray as the new Chairman of Aptuit Holdings, LLC

    Aptuit announces enhancement of integrated IND enabling services

    Tim Tyson to leave as Chairman of Aptuit

    Aptuit LLC and Dimension Therapeutics enter strategic partnership to advance select Dimension programs toward IND filing

    Henning Steinhagen appointed as Executive Vice President Drug Discovery and Development and Site-Head Verona

    Aptuit obtains renewal of French CIR tax accreditation

    Aptuit announces acquisition of Kuecept Ltd

    Iain Rusling, Appointed VP of Quality Management and EHS

    Aptuit announces acquisition of Exquiron Biotech AG

    Vince Russell, Appointed Respiratory Discovery Director

    Aptuit and Icagen agree to strategic alliance

    Mario Maio, Appointed Global Head of CMC

    Appointment of Aptuit as a member of EU-NETVAL

    Aptuit announces 16M$ investment in capacity and capability

    Aptuit CEO, Jonathan Goldman, joins the Columbia University Healthcare Advisory Board

     

     

    Contact us

    Evotec

    Business Development

    T +44.(0)1235.86 15 61 T +1.732 329 2355 x3308